Cure Media Group, LLC.
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 800-210-2873

Copyright © 2019
CURE Media Group.
All rights reserved.
Cure Media Group, LLC. All Rights Reserved.
CURE does not provide medical, diagnostic, or treatment advice.

Kidney Cancer

Combination Therapies Open New Doors in Renal Cell Carcinoma Studies

Bradley McGregor, M.D.

Utilizing the data of the CheckMate 9ER trial, researchers believe that combination therapies in the treatment of patients with renal cell carcinoma are the future of the landscape.

New Issue Alert: CURE Winter 2020

Katie Kosko and Jessica Skarzynski

Here’s a look at what’s inside our 2020 Winter issue.

Aiming for Long Term Success in Kidney Cancer Treatment

Jessica Skarzynski

Treatments for Renal Cell Carcinoma are showing effectiveness in the short term, but with the help of new trials, researchers are looking to expand their impact for long term treatment.

Immune Checkpoint Inhibition Could Be the Future of Renal Cell Carcinoma Treatment

Dr. Thomas Powles

The landscape for patients with renal cell carcinoma could potentially change as the use of immune checkpoint inhibition shows promise for these patients.

Novel Agent Shows Promise in Patients with Clear Cell Renal Cell Carcinoma

Kristie L. Kahl

MK-6482 demonstrated an objective response rate of 24% among patients with advanced clear cell renal cell carcinoma, according to study findings presented at the 2020 Genitourinary Cancers Symposium.

Long-Term Follow-Up Supports Treatment with Opdivo in Advanced Renal Cell Carcinoma

Kristie L. Kahl

After five years of follow-up, treatment with Opdivo in those with previously treated advanced or metastatic renal cell carcinoma induced superior survival outcomes.

Opdivo-Yervoy Combo Induces Superior Long-Term Outcomes in Patients with RCC

Kristie L. Kahl

More than 50% of patients with previously untreated advanced or metastatic renal cell carcinoma were alive at 42 months after being treated with Opdivo plus Yervoy.

Childhood Body Mass Index Plays a Role in Kidney Cancer Risk as an Adult

Conor Killmurray

Children with higher birth weight and body mass index, as well as taller height, are at a greater risk of developing renal cell carcinoma later in life, according to new study findings.

Anti-PD-1 Therapy May Induce Better Survival Outcomes Compared With Anti-PD-L1

Kristie L. Kahl

Findings from a recent study supported further evaluation of comparing anti–PD-1 to anti–PD-L1 therapy to help determine treatment options for patients with cancer.

Individualized Treatment Plans Improve Outcomes in Kidney Cancer

Jessica Skarzynski

Personalized treatments have changed the cancer landscape, and continue to change it for patients with renal cell carcinoma.

Kidney Cancer

Sign In